Dennis Klinkhammer

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Molecularly Imprinted

Decision Making

Top Venues

Cost effectiveness and resource allocation : C/E

This page only lists publications with an associated author ORCID identifier.

Publications

Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)
Amelie Wickmann, Melina Sophie Kurte, Julia Jeck, Luisa Camacho, Dennis Klinkhammer, Florian Kron, Robert Dengler
Cost-benefit evaluation of advanced therapy lines in metastatic triple-negative breast cancer in Germany. Cost effectiveness and resource allocation : C/E 22 (1) (2024)